Software - Application
Build Your Comparison
Side-by-side financial analysisStock Comparison
CYN vs IROQ vs NECB vs LIDR vs NBTB
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Auto - Parts
Banks - Regional
CYN vs IROQ vs NECB vs LIDR vs NBTB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Banks - Regional | Banks - Regional | Auto - Parts | Banks - Regional |
| Market Cap | $14M | $89M | $359M | $74M | $2.52B |
| Revenue (TTM) | $276K | $48M | $156M | $270K | $902M |
| Net Income (TTM) | $-26M | $5M | $44M | $-34M | $169M |
| Gross Margin | 34.4% | 59.5% | 65.9% | -144.1% | 73.6% |
| Operating Margin | -99.2% | 14.9% | 39.8% | -125.8% | 24.3% |
| Forward P/E | — | 19.4x | 8.3x | — | 11.5x |
| Total Debt | $7M | $73M | $75M | $235K | $327M |
| Cash & Equiv. | $990K | $20M | $81M | $43M | $185M |
CYN vs IROQ vs NECB vs LIDR vs NBTB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | Jun 26 | Return |
|---|---|---|---|
| Cyngn Inc. (CYN) | 100 | 0.0 | -100.0% |
| IF Bancorp, Inc. (IROQ) | 100 | 123.2 | +23.2% |
| Northeast Community… (NECB) | 100 | 237.0 | +137.0% |
| AEye, Inc. (LIDR) | 100 | 1.0 | -99.0% |
| NBT Bancorp Inc. (NBTB) | 100 | 131.3 | +31.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CYN vs IROQ vs NECB vs LIDR vs NBTB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CYN plays a supporting role in this comparison — it may shine differently against other peers.
IROQ lags the leaders in this set but could rank higher in a more targeted comparison.
NECB carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.71, yield 3.8%
- 5.0% 10Y total return vs NBTB's 108.5%
- PEG 0.25 vs NBTB's 1.64
- Beta 0.71, yield 3.8%, current ratio 0.06x
LIDR is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 15.3%, EPS growth 79.9%, 3Y rev CAGR -60.0%
- 15.3% revenue growth vs CYN's -40.5%
- +86.2% vs CYN's -72.6%
NBTB is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.76, Low D/E 17.3%, current ratio 1.60x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.3% revenue growth vs CYN's -40.5% | |
| Value | Lower P/E (8.3x vs 11.5x), PEG 0.25 vs 1.64 | |
| Quality / Margins | 28.4% margin vs LIDR's -127.0% | |
| Stability / Safety | Beta 0.71 vs LIDR's 2.51 | |
| Dividends | 3.8% yield, 2-year raise streak, vs NBTB's 3.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +86.2% vs CYN's -72.6% | |
| Efficiency (ROA) | 2.2% ROA vs LIDR's -48.5%, ROIC 12.5% vs -100.7% |
CYN vs IROQ vs NECB vs LIDR vs NBTB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
CYN vs IROQ vs NECB vs LIDR vs NBTB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NECB leads in 3 of 6 categories
CYN leads 0 • IROQ leads 0 • LIDR leads 0 • NBTB leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NECB leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $902M annually — 3341.6x LIDR's $270,000. NECB is the more profitable business, keeping 28.4% of every revenue dollar as net income compared to LIDR's -127.0%. On growth, CYN holds the edge at +121.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $276,397 | $48M | $156M | $270,000 | $902M |
| EBITDAEarnings before interest/tax | -$26M | $7M | $63M | -$34M | $241M |
| Net IncomeAfter-tax profit | -$26M | $5M | $44M | -$34M | $169M |
| Free Cash FlowCash after capex | -$27M | $6M | $51M | -$29M | $225M |
| Gross MarginGross profit ÷ Revenue | +34.4% | +59.5% | +65.9% | -144.1% | +73.6% |
| Operating MarginEBIT ÷ Revenue | -99.2% | +14.9% | +39.8% | -125.8% | +24.3% |
| Net MarginNet income ÷ Revenue | -94.2% | +10.8% | +28.4% | -127.0% | +18.8% |
| FCF MarginFCF ÷ Revenue | -97.1% | +12.4% | +32.5% | -106.7% | +24.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +121.8% | — | — | +57.8% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +91.1% | +115.0% | +6.8% | -63.6% | +39.5% |
Valuation Metrics
NECB leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 8.0x trailing earnings, NECB trades at a 59% valuation discount to IROQ's 19.4x P/E. Adjusting for growth (PEG ratio), NECB offers better value at 0.24x vs NBTB's 2.06x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $14M | $89M | $359M | $74M | $2.5B |
| Enterprise ValueMkt cap + debt − cash | $19M | $142M | $353M | $31M | $2.7B |
| Trailing P/EPrice ÷ TTM EPS | -0.24x | 19.38x | 7.99x | -1.78x | 14.47x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 8.30x | — | 11.54x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.24x | — | 2.06x |
| EV / EBITDAEnterprise value multiple | — | 21.69x | 5.57x | — | 11.03x |
| Price / SalesMarket cap ÷ Revenue | 62.34x | 1.84x | 2.28x | 318.04x | 2.90x |
| Price / BookPrice ÷ Book value/share | 0.15x | 1.02x | 1.01x | 0.74x | 1.29x |
| Price / FCFMarket cap ÷ FCF | — | 13.65x | 7.07x | — | 11.49x |
Profitability & Efficiency
NECB leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
NECB delivers a 13.1% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $-60 for CYN. LIDR carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to IROQ's 0.89x. On the Piotroski fundamental quality scale (0–9), IROQ scores 7/9 vs CYN's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -59.6% | +6.2% | +13.1% | -56.2% | +9.5% |
| ROA (TTM)Return on assets | -48.1% | +0.6% | +2.2% | -48.5% | +1.1% |
| ROICReturn on invested capital | -117.2% | +2.9% | +12.5% | -100.7% | +7.9% |
| ROCEReturn on capital employed | -71.5% | +3.9% | +16.2% | -64.7% | +2.4% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 5 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.18x | 0.89x | 0.21x | 0.00x | 0.17x |
| Net DebtTotal debt minus cash | $6M | $53M | -$6M | -$43M | $142M |
| Cash & Equiv.Liquid assets | $990,023 | $20M | $81M | $43M | $185M |
| Total DebtShort + long-term debt | $7M | $73M | $75M | $235,000 | $327M |
| Interest CoverageEBIT ÷ Interest expense | -59.79x | 2.72x | 1.17x | -80.57x | 1.05x |
Total Returns (Dividends Reinvested)
Evenly matched — IROQ and NECB each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NECB five years ago would be worth $24,194 today (with dividends reinvested), compared to $0 for CYN. Over the past 12 months, LIDR leads with a +86.2% total return vs CYN's -72.6%. The 3-year compound annual growth rate (CAGR) favors IROQ at 26.0% vs CYN's -95.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -54.9% | -1.6% | +15.9% | -24.2% | +17.6% |
| 1-Year ReturnPast 12 months | -72.6% | +11.1% | +17.5% | +86.2% | +18.3% |
| 3-Year ReturnCumulative with dividends | -100.0% | +99.9% | +98.4% | -70.4% | +48.5% |
| 5-Year ReturnCumulative with dividends | -100.0% | +25.4% | +141.9% | -99.5% | +44.4% |
| 10-Year ReturnCumulative with dividends | -100.0% | +60.1% | +500.4% | -99.5% | +108.5% |
| CAGR (3Y)Annualised 3-year return | -95.5% | +26.0% | +25.6% | -33.4% | +14.1% |
Risk & Volatility
Evenly matched — IROQ and NECB each lead in 1 of 2 comparable metrics.
Risk & Volatility
IROQ is the less volatile stock with a -0.05 beta — it tends to amplify market swings less than LIDR's 2.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NECB currently trades 99.8% from its 52-week high vs CYN's 3.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.18x | -0.05x | 0.71x | 2.51x | 0.76x |
| 52-Week HighHighest price in past year | $41.54 | $29.00 | $26.02 | $6.44 | $48.27 |
| 52-Week LowLowest price in past year | $1.22 | $23.21 | $19.27 | $0.71 | $39.20 |
| % of 52W HighCurrent price vs 52-week peak | +3.0% | +91.6% | +99.8% | +24.8% | +99.8% |
| RSI (14)Momentum oscillator 0–100 | 36.0 | 34.4 | 67.0 | 36.7 | 63.1 |
| Avg Volume (50D)Average daily shares traded | 277K | 103K | 33K | 3.4M | 266K |
Analyst Outlook
Evenly matched — NECB and NBTB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NECB as "Hold", LIDR as "Hold", NBTB as "Hold". Consensus price targets imply 650.0% upside for LIDR (target: $12) vs -4.5% for NBTB (target: $46). For income investors, NECB offers the higher dividend yield at 3.75% vs IROQ's 1.54%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | — | — | — | $12.00 | $46.00 |
| # AnalystsCovering analysts | — | — | 1 | 4 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | +1.5% | +3.8% | — | +3.0% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 2 | — | 13 |
| Dividend / ShareAnnual DPS | — | $0.41 | $0.98 | — | $1.43 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.4% | 0.0% | +0.4% |
NECB leads in 3 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 3 categories are tied.
CYN vs IROQ vs NECB vs LIDR vs NBTB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CYN or IROQ or NECB or LIDR or NBTB a better buy right now?
For growth investors, AEye, Inc.
(LIDR) is the stronger pick with 15. 3% revenue growth year-over-year, versus -40. 5% for Cyngn Inc. (CYN). Northeast Community Bancorp, Inc. (NECB) offers the better valuation at 8. 0x trailing P/E (8. 3x forward), making it the more compelling value choice. Analysts rate Northeast Community Bancorp, Inc. (NECB) a "Hold" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CYN or IROQ or NECB or LIDR or NBTB?
On trailing P/E, Northeast Community Bancorp, Inc.
(NECB) is the cheapest at 8. 0x versus IF Bancorp, Inc. at 19. 4x. On forward P/E, Northeast Community Bancorp, Inc. is actually cheaper at 8. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Northeast Community Bancorp, Inc. wins at 0. 25x versus NBT Bancorp Inc. 's 1. 64x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CYN or IROQ or NECB or LIDR or NBTB?
Over the past 5 years, Northeast Community Bancorp, Inc.
(NECB) delivered a total return of +141. 9%, compared to -100. 0% for Cyngn Inc. (CYN). Over 10 years, the gap is even starker: NECB returned +500. 4% versus CYN's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CYN or IROQ or NECB or LIDR or NBTB?
By beta (market sensitivity over 5 years), IF Bancorp, Inc.
(IROQ) is the lower-risk stock at -0. 05β versus AEye, Inc. 's 2. 51β — meaning LIDR is approximately -4752% more volatile than IROQ relative to the S&P 500. On balance sheet safety, AEye, Inc. (LIDR) carries a lower debt/equity ratio of 0% versus 89% for IF Bancorp, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CYN or IROQ or NECB or LIDR or NBTB?
By revenue growth (latest reported year), AEye, Inc.
(LIDR) is pulling ahead at 15. 3% versus -40. 5% for Cyngn Inc. (CYN). On earnings-per-share growth, the picture is similar: IF Bancorp, Inc. grew EPS 140. 4% year-over-year, compared to -7. 7% for Northeast Community Bancorp, Inc.. Over a 3-year CAGR, CYN leads at -5. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CYN or IROQ or NECB or LIDR or NBTB?
Northeast Community Bancorp, Inc.
(NECB) is the more profitable company, earning 28. 2% net margin versus -145. 7% for AEye, Inc. — meaning it keeps 28. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NECB leads at 39. 6% versus -136. 2% for LIDR. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CYN or IROQ or NECB or LIDR or NBTB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Northeast Community Bancorp, Inc. (NECB) is the more undervalued stock at a PEG of 0. 25x versus NBT Bancorp Inc. 's 1. 64x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Northeast Community Bancorp, Inc. (NECB) trades at 8. 3x forward P/E versus 11. 5x for NBT Bancorp Inc. — 3. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LIDR: 650. 0% to $12. 00.
08Which pays a better dividend — CYN or IROQ or NECB or LIDR or NBTB?
In this comparison, NECB (3.
8% yield), NBTB (3. 0% yield), IROQ (1. 5% yield) pay a dividend. CYN, LIDR do not pay a meaningful dividend and should not be held primarily for income.
09Is CYN or IROQ or NECB or LIDR or NBTB better for a retirement portfolio?
For long-horizon retirement investors, IF Bancorp, Inc.
(IROQ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 05), 1. 5% yield). Cyngn Inc. (CYN) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IROQ: +60. 1%, CYN: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CYN and IROQ and NECB and LIDR and NBTB?
These companies operate in different sectors (CYN (Technology) and IROQ (Financial Services) and NECB (Financial Services) and LIDR (Consumer Cyclical) and NBTB (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CYN is a small-cap quality compounder stock; IROQ is a small-cap quality compounder stock; NECB is a small-cap deep-value stock; LIDR is a small-cap high-growth stock; NBTB is a small-cap deep-value stock. IROQ, NECB, NBTB pay a dividend while CYN, LIDR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.